Joint Formulary & PAD

Loperamide hydrochloride - Short bowel syndrome

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Capsules
  • Oro-dispersible
  • Tablets
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important
Reserve orodispersible tablets (Melts) for patients in whom the tablets or capsules are not suitable. Initiation and first month supply by the specialist before transfer of prescribing to primary care.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Loperamide hydrochloride
Indication :
Short bowel syndrome
Group Name :
Keywords :
Brand Names Include :
Norimode, Imodium, Loritax
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Loperamide hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Short bowel syndrome.

Committee Recommendations (0)

  • No records returned.